Androgen deprivation therapy and the risk of tenosynovitis in prostate cancer patients

Objectives Androgen deprivation therapy (ADT) use in prostate cancer (PCa) patients has been reported to have an association with rheumatoid arthritis. We aimed to assess the impact of ADT on the subsequent risk of tenosynovitis.